文献速递系统性红斑狼疮

SLE遗传易感位点与儿童及成人起病SLE狼疮肾炎的关联

Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset SLE.
PubMed 文献 · Rheumatology (Oxford) · 2020-01-01

研究基于多伦多两个三级中心SLE队列(1237例,其中cSLE 572例、aSLE 665例),分析HLA和非HLA的SLE风险加权遗传风险评分(GRS)与活检证实的狼疮肾炎(LN)风险的关联。结果显示非HLA GRS升高与LN风险增加显著相关(OR=1.26),欧洲人群中HLA GRS亦与LN风险相关(OR=1.55),且在欧洲cSLE患者中关联趋势更强;限制为增殖性LN时关联幅度增大。

要点

  • 非HLA GRS升高与LN风险增加显著相关(OR=1.26,95%CI 1.09–1.46)。
  • 欧洲人群中HLA GRS与LN风险相关(OR=1.55,95%CI 1.07–2.25)。
  • 增殖性LN中非HLA和HLA GRS关联幅度均增大(OR分别1.30和1.99)。

核心结论

  • 已知SLE风险位点与儿童和成人SLE患者的LN风险存在关联,欧洲cSLE患者中效应最强。

研究设计与样本

  • 研究纳入多伦多两个三级中心SLE队列,cSLE为诊断年龄<18岁,aSLE为诊断年龄≥18岁。
  • 患者符合ACR和/或SLICC SLE分类标准,并采用Illumina Multi-Ethnic Global Array或Omni1-Quad芯片进行基因分型。
  • 共1237例参与者,其中cSLE 572例(41%有LN),aSLE 665例(30%有LN)。
  • 采用logistic模型检验HLA和非HLA加性SLE风险加权GRS与LN风险的关联,按cSLE/aSLE和 ancestry 分层,并对分层效应估计进行meta分析。

主要发现

  • 非HLA GRS升高与LN风险增加显著相关(OR=1.26;95%CI 1.09,1.46;P=0.0006)。
  • 欧洲人群中HLA GRS升高与LN风险相关(OR=1.55;95%CI 1.07,2.25;P=0.03)。
  • 在欧洲cSLE患者中,两种GRS与LN风险的关联趋势均强于aSLE患者。
  • 限制为增殖性LN时,非HLA GRS关联幅度增大(OR=1.30;95%CI 1.10,1.52;P=0.002),HLA GRS关联幅度亦增大(OR=1.99;95%CI 1.29,3.08;P=0.002)。

关键数值与推荐

  • LN定义为活检证实的狼疮肾炎。
  • cSLE定义为诊断年龄<18岁,aSLE定义为诊断年龄≥18岁。
  • 患者符合ACR和/或SLICC SLE分类标准。

临床怎么用

  • 对于SLE患者,尤其是欧洲cSLE患者,可考虑结合HLA和非HLA GRS评估LN风险。
  • GRS与增殖性LN的关联更强,提示遗传风险评分可能有助于识别高危LN患者。

局限性

  • 研究未纳入非欧洲祖先群体特有的SLE风险单核苷酸多态性。
  • 研究结果尚未在独立队列中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: LN is one of the most common and severe manifestations of SLE. Our aim was to test the association of SLE risk loci with LN risk in childhood-onset SLE (cSLE) and adult-onset SLE (aSLE). METHODS: Two Toronto-based tertiary care SLE cohorts included cSLE (diagnosed <18 years) and aSLE patients (diagnosed ⩾18 years). Patients met ACR and/or SLICC SLE criteria and were genotyped on the Illumina Multi-Ethnic Global Array or Omni1-Quad arrays. We identified those with and without biopsy-confirmed LN. HLA and non-HLA additive SLE risk-weighted genetic risk scores (GRSs) were tested for association with LN risk in logistic models, stratified by cSLE/aSLE and ancestry. Stratified effect estimates were meta-analysed. RESULTS: Of 1237 participants, 572 had cSLE (41% with LN) and 665 had aSLE (30% with LN). Increasing non-HLA GRS was significantly associated with increased LN risk [odds ratio (OR) = 1.26; 95% CI 1.09, 1.46; P = 0.0006], as was increasing HLA GRS in Europeans (OR = 1.55; 95% CI 1.07, 2.25; P = 0.03). There was a trend for stronger associations between both GRSs and LN risk in Europeans with cSLE compared with aSLE. When restricting cases to proliferative LN, the magnitude of these associations increased for both the non-HLA (OR = 1.30; 95% CI 1.10, 1.52; P = 0.002) and HLA GRS (OR = 1.99; 95% CI 1.29, 3.08; P = 0.002). CONCLUSION: We observed an association between known SLE risk loci and LN risk in children and adults with SLE, with the strongest effect observed among Europeans with cSLE. Future studies will include SLE-risk single nucleotide polymorphisms specific to non-European ancestral groups and validate findings in an independent cohort.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Webber D, Cao J, Dominguez D, et al. Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset SLE. Rheumatology (Oxford). 2020. PMID: 31236574. doi:10.1093/rheumatology/kez220

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。